Preview

Rational Pharmacotherapy in Cardiology

Advanced search

CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE

https://doi.org/10.20996/1819-6446-2015-11-2-159-164

Full Text:

Abstract

Clinical case history of endovascular intervention in infarct related coronary artery with 4 sirolimus-eluting stents implantation and their further thrombosis during early postoperative period is described. Percutaneous coronary intervention was successful after the balanced medication with 2 antiplatelet drugs (acetylsalicylic acid and clopidogrel) and heparin. There were not any reasons for additional prescription of antiplatelet medicine. It seems that one of the main reasons of the stent thrombosis was the extended area of 4 sirolimus-eluting stents implantation into the affected vessel. After the analysis of our clinical case history we propose that for stent thrombosis prevention in multistent (≥4 drugeluting stents) interventions it is necessary to apply additional antiplatelet drug – glycoprotein IIb/IIIa inhibitor eptifibatide.

About the Authors

K. A. Kireev
Road Clinical Hospital at Chelyabinsk station, JSC "Russian Railways", South Ural State Medical University
Russian Federation

Dovatora ul. 23, Chelyabinsk, 454048 Russia

Vorovskogo ul. 64, Chelyabinsk, 454092 Russia



A. V. Krasnopeev
Road Clinical Hospital at Chelyabinsk station, JSC "Russian Railways"
Russian Federation
Dovatora ul. 23, Chelyabinsk, 454048 Russia


T. S. Kireeva
South Ural State Medical University
Russian Federation

Vorovskogo ul. 64, Chelyabinsk, 454092 Russia



References

1. Bokeria LA, Alekyan BG. Endovascular diagnosis and treatment of diseases of the heart and blood vessels in the Russian Federation. Moscow: NTsSSKh im. A. N. Bakuleva RAMN; 2013. Russian (Бокерия Л.А., Алекян Б.Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации. М.: НЦССХ им. А. Н. Бакулева РАМН; 2013).

2. National guidelines for diagnosis and treatment of patients with acute myocardial infarction with STsegment elevation ECG. Kardiovaskulyarnaya Terapiya i Profilaktika 2007; 6 (8) suppl 1: 1-64. Russian (Национальные рекомендации по диагностике и лечению больных острым инфарктом мио-карда с подъемом сегмента ST ЭКГ. Кардиоваскулярная Терапия и Профилактика 2007;6 (8) при-ложение 1: 1-64).

3. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011 ;32(23):2999-3054.

4. Sulimov VA. Antithrombotic therapy for percutaneous coronary intervention. Ration Pharmacother Card 2008; (3): 91-100. Russian (Сулимов В.А. Антитромботическая терапия при чрескожных коро-нарных вмешательствах. Рациональная Фармакотерапия в Кардиологии 2008; 3: 91-100).

5. Levitsky IV, Samko AN, Merkulov EV, et al. The second-generation drug-eluting stents. Coronary stent coated with zotarolimus. Atmosfera. Novosti kardiologii 2011; 3: 17-21. Russian (Левицкий И.В., Сам-ко А.Н., Меркулов Е.В., и др. Второе поколение стентов с лекарственным покрытием. Коронар-ный стент с покрытием зотаролимус. Атмосфера. Новости кардиологии 2011; 3: 17-21).

6. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35(37):2541-619.


For citation:


Kireev K.A., Krasnopeev A.V., Kireeva T.S. CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE. Rational Pharmacotherapy in Cardiology. 2015;11(2):159-164. (In Russ.) https://doi.org/10.20996/1819-6446-2015-11-2-159-164

Views: 329


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)